GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its ...

The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to treat ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

GSK (LSE:GSK) announced that the European Medicines Agency accepted its regulatory application to expand the use of its RSV ...

Roche (SIX:ROG) shares dropped 2% on Monday after the company paused dosing of its gene therapy Elevidys in non-ambulatory ...

EMA committee recommends approval of Biobhyo, a vaccine against swine dysentery disease in pigs: Amsterdam, The Netherlands Monday, June 16, 2025, 12:00 Hrs [IST] European Medicin ...

Cinclus Pharma AB (publ), a clinical-stage pharmaceutical company developing next generation treatments for acid-related diseases, today announced that the European Medicines Agency (EMA) and the US F ...

A research team at the University of Barcelona shows how allopurinol may prevent aortic aneurysm in Marfan syndrome, paving the way for new clinical trials.

FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as ...

Skepticism still persists around the use of measurable residual disease (MRD) for clinical and regulatory decision-making in ...

Ilunocitinib tablets are currently available in Brazil, Canada and Japan, in addition to the US. Elanco noted that, once the ...